ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $472,000 | -50.9% | 189,600 | -22.1% | 0.22% | -51.8% |
Q1 2019 | $961,000 | +92.2% | 243,400 | +189.9% | 0.46% | +109.2% |
Q1 2017 | $500,000 | -15.5% | 83,958 | 0.0% | 0.22% | -24.8% |
Q4 2016 | $592,000 | +107.0% | 83,958 | +47.8% | 0.29% | +154.4% |
Q3 2016 | $286,000 | +17.2% | 56,800 | -17.1% | 0.11% | +5.6% |
Q2 2016 | $244,000 | -14.4% | 68,495 | +10.8% | 0.11% | +6.9% |
Q1 2016 | $285,000 | – | 61,817 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |